SE_02_133000270 |
chr8:95073267-95135912 |
Sample_02_1330 |
Blood |
AMU-AML1 |
270 |
19 |
1624 |
216 | 5 | 51 |
297 |
PLEKHF2,MIR3150B,NDUFAF6,MIR3150A |
SE_02_039400079 |
chr8:95083775-95153404 |
Sample_02_0394 |
Mammary gland |
T-47D_2 |
79 |
15 |
1763 |
221 | 5 | 55 |
186 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_010500241 |
chr8:95084490-95144704 |
Sample_02_0105 |
Skin |
neonatal_keratinocytes |
241 |
7 |
1530 |
193 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_108700049 |
chr8:95084667-95144168 |
Sample_02_1087 |
Mammary gland |
T47D_shCtrl_shRING1B_0 |
49 |
14 |
1514 |
190 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_108600059 |
chr8:95084728-95144450 |
Sample_02_1086 |
Mammary gland |
T47D_shCtrl_0hr |
59 |
16 |
1513 |
190 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_040300209 |
chr8:95084753-95144279 |
Sample_02_0403 |
Mammary gland |
T-47D_untreat |
209 |
8 |
1512 |
190 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_053200073 |
chr8:95084905-95153593 |
Sample_02_0532 |
Mammary gland |
T47D |
73 |
23 |
1739 |
219 | 5 | 56 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_108900118 |
chr8:95084929-95143505 |
Sample_02_1089 |
Mammary gland |
T47D_shCtrl_shRING1B_45min |
118 |
16 |
1491 |
189 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_109200164 |
chr8:95084984-95144076 |
Sample_02_1092 |
Mammary gland |
T47D_shCtrl_24hr |
164 |
17 |
1500 |
189 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_123400240 |
chr8:95085174-95143753 |
Sample_02_1234 |
Mammary gland |
T47D_Full |
240 |
16 |
1488 |
189 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_007900069 |
chr8:95085179-95139586 |
Sample_02_0079 |
Mammary gland |
T-47D_1 |
69 |
11 |
1390 |
181 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_122900683 |
chr8:95086205-95152789 |
Sample_02_1229 |
Haematopoietic and lymphoid tissue bone marrow |
K562_Control |
683 |
17 |
1686 |
211 | 5 | 54 |
186 |
PLEKHF2,MIR3150B,MIR3150A,NDUFAF6,C8orf37,CCNE2 |
SE_02_044700360 |
chr8:95087668-95137290 |
Sample_02_0447 |
Lung |
lung metastasis from primary osteosarcoma tumor M2 |
360 |
10 |
1272 |
162 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_153900864 |
chr8:95087898-95131040 |
Sample_02_1539 |
Nasopharyngeal |
C666-1 |
864 |
18 |
1132 |
145 | 5 | 26 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_044500787 |
chr8:95087938-95182169 |
Sample_02_0445 |
Lung |
lung metastasis from primary osteosarcoma tumor M10 |
787 |
30 |
2355 |
231 | 6 | 118 |
389 |
PLEKHF2,MIR3150B,MIR3150A,LINC01298 |
SE_02_064800664 |
chr8:95087958-95137072 |
Sample_02_0648 |
Tracheobronchial epithelial |
HTBE_H3N2_03h |
664 |
14 |
1251 |
158 | 5 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_115500104 |
chr8:95089708-95191534 |
Sample_02_1155 |
Lymphoma |
RL_R1446C_gRNA1_KDAC005 |
104 |
16 |
2610 |
236 | 5 | 131 |
389 |
PLEKHF2,MIR3150B,MIR3150A,LINC01298 |
SE_02_020200463 |
chr8:95092500-95114501 |
Sample_02_0202 |
Stomach |
YCC7 |
463 |
7 |
595 |
81 | 3 | 13 |
0 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_020800278 |
chr8:95093123-95114488 |
Sample_02_0208 |
Stomach |
YCC3 |
278 |
5 |
578 |
76 | 3 | 13 |
0 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_154100549 |
chr8:95096117-95152238 |
Sample_02_1541 |
Nasopharyngeal |
HNE1 |
549 |
16 |
1387 |
154 | 3 | 54 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_076500154 |
chr8:95096139-95150337 |
Sample_02_0765 |
Prostate |
22RV1-DHT-DMSO_6h |
154 |
14 |
1335 |
146 | 3 | 54 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_081700977 |
chr8:95097382-95116642 |
Sample_02_0817 |
Ovary |
Epithelial ovarian cancer |
977 |
5 |
520 |
61 | 3 | 20 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_077501359 |
chr8:95097476-95145815 |
Sample_02_0775 |
Pancreas |
EndoC-BH1_SE |
1359 |
11 |
1200 |
123 | 3 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_125800996 |
chr8:95097550-95115115 |
Sample_02_1258 |
Liver |
Pancreatic cancer cells derived from liver metastasis |
996 |
5 |
482 |
59 | 3 | 17 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_01_005800066 |
chr8:95098441-95115998 |
Sample_01_0058 |
Prostate |
PC-3 |
66 |
2 |
470 |
57 | 3 | 18 |
0 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_071800438 |
chr8:95098675-95114935 |
Sample_02_0718 |
Pancreas |
PATU8988S_GFP_DOX |
438 |
4 |
439 |
52 | 3 | 15 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_127500548 |
chr8:95098744-95114483 |
Sample_02_1275 |
Prostate |
PC3_Vorinostat |
548 |
10 |
430 |
49 | 2 | 11 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_127400307 |
chr8:95098773-95115358 |
Sample_02_1274 |
Prostate |
PC3_DMSO |
307 |
10 |
448 |
54 | 3 | 17 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_018400452 |
chr8:95099081-95138350 |
Sample_02_0184 |
Skin |
SKMEL30 |
452 |
7 |
981 |
101 | 3 | 50 |
186 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_019600327 |
chr8:95099139-95114650 |
Sample_02_0196 |
Stomach |
NCC59 |
327 |
4 |
421 |
49 | 2 | 15 |
0 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_156400186 |
chr8:95099390-95114386 |
Sample_02_1564 |
Gastrointestinal Stromal |
GIST-430 |
186 |
4 |
414 |
47 | 2 | 11 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_01_000200078 |
chr8:95099478-95115145 |
Sample_01_0002 |
Prostate |
22Rv1_10nM17beta-hydroxy-5alpha-androstan-3-one |
78 |
2 |
424 |
52 | 3 | 15 |
0 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_077400116 |
chr8:95099497-95115493 |
Sample_02_0774 |
Prostate |
22Rv1_delSite1_Clone11/12-D8 |
116 |
2 |
431 |
52 | 3 | 18 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_01_000100079 |
chr8:95099520-95115728 |
Sample_01_0001 |
Prostate |
22Rv1 |
79 |
3 |
433 |
52 | 3 | 18 |
0 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_077200092 |
chr8:95099555-95115316 |
Sample_02_0772 |
Prostate |
22Rv1_delSite1_Clone11/12-F6 |
92 |
7 |
424 |
52 | 3 | 15 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_048000612 |
chr8:95099567-95152003 |
Sample_02_0480 |
Gingival epithelial |
HGEP |
612 |
14 |
1287 |
138 | 3 | 52 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_077300099 |
chr8:95099880-95115347 |
Sample_02_0773 |
Prostate |
22Rv1_delSite4_Clone22/23-F8 |
99 |
4 |
413 |
50 | 3 | 14 |
0 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_039601543 |
chr8:95110749-95142661 |
Sample_02_0396 |
Skin |
NHEK-D |
1543 |
7 |
754 |
72 | 1 | 41 |
186 |
PLEKHF2,MIR3150B,MIR3150 |
SE_01_005300080 |
chr8:95112415-95183790 |
Sample_01_0053 |
Haematopoietic and lymphoid tissue |
OCI-LY1 |
80 |
11 |
1728 |
126 | 2 | 107 |
389 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_078400811 |
chr8:95114155-95146119 |
Sample_02_0784 |
Blood |
OSU-CLL |
811 |
12 |
741 |
69 | 1 | 40 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_02_115200043 |
chr8:95114427-95191128 |
Sample_02_1152 |
Lymphoma |
RL_WT_gRNA1 |
43 |
9 |
1928 |
142 | 2 | 118 |
389 |
PLEKHF2,MIR3150B,MIR3150A,LINC01298 |
SE_02_028800147 |
chr8:95114542-95182449 |
Sample_02_0288 |
Tonsil |
CB5_H3K27Ac |
147 |
9 |
1638 |
121 | 2 | 105 |
389 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_106500056 |
chr8:95114603-95195913 |
Sample_02_1065 |
Lymphoma |
KARPAS-422_DMSO_8d |
56 |
27 |
2056 |
149 | 2 | 121 |
389 |
PLEKHF2,MIR3150B,MIR3150A,LINC01298 |
SE_02_130200058 |
chr8:95114688-95191009 |
Sample_02_1302 |
Lymphoma |
RL DMSO |
58 |
15 |
1920 |
142 | 2 | 114 |
389 |
PLEKHF2,MIR3150B,MIR3150A,LINC01298 |
SE_01_002000151 |
chr8:95115060-95185163 |
Sample_01_0020 |
Blood |
B-cell |
151 |
6 |
1703 |
120 | 1 | 105 |
389 |
PLEKHF2,MIR3150B,MIR3150 |
SE_01_008400816 |
chr8:95115220-95182663 |
Sample_01_0084 |
Spleen |
spleen |
816 |
17 |
1627 |
117 | 1 | 101 |
389 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_142901029 |
chr8:95115334-95155918 |
Sample_02_1429 |
Blood |
GM12878_WT |
1029 |
11 |
949 |
90 | 0 | 66 |
338 |
PLEKHF2,MIR3150B,MIR3150A,C8orf37 |
SE_02_109800732 |
chr8:95115548-95137965 |
Sample_02_1098 |
Blood |
THP1_DMSO_noPMA |
732 |
6 |
531 |
46 | 0 | 32 |
186 |
PLEKHF2,MIR3150B,MIR3150A |
SE_01_005500275 |
chr8:95116511-95191964 |
Sample_01_0055 |
Haematopoietic and lymphoid tissue |
OCI-LY7 |
275 |
10 |
1899 |
136 | 1 | 111 |
389 |
PLEKHF2,MIR3150B,MIR3150 |
SE_02_149301059 |
chr8:95123676-95138293 |
Sample_02_1493 |
Skin |
SK-MEL-5_DMSO_6h |
1059 |
4 |
311 |
31 | 0 | 30 |
186 |
PLEKHF2 |
SE_02_099900115 |
chr8:95125200-95168348 |
Sample_02_0999 |
Lymphoma |
OCI-LY1_966 |
115 |
20 |
966 |
88 | 0 | 89 |
389 |
PLEKHF2,LINC01298 |
SE_02_099800223 |
chr8:95125201-95168326 |
Sample_02_0998 |
Lymphoma |
OCI-LY1_DMSO |
223 |
30 |
964 |
88 | 0 | 89 |
389 |
PLEKHF2,LINC01298 |
SE_01_006700182 |
chr8:95126460-95167449 |
Sample_01_0067 |
Peritoneal effusion: derived from metastatic site: peritoneal cavity |
SUDHL6 |
182 |
1 |
912 |
85 | 0 | 84 |
389 |
PLEKHF2 |
SE_02_146800466 |
chr8:95126500-95168816 |
Sample_02_1468 |
Blood |
HUDEP-2_WT |
466 |
11 |
948 |
87 | 0 | 85 |
389 |
PLEKHF2,LINC01298 |
SE_02_021300276 |
chr8:95128355-95191781 |
Sample_02_0213 |
Burkitts lymphoma of the left maxilla |
Raji_JQ1 |
276 |
6 |
1572 |
110 | 1 | 105 |
389 |
PLEKHF2 |
SE_02_012100157 |
chr8:95128416-95161206 |
Sample_02_0121 |
Haematopoietic and lymphoid tissue |
SUDHL-4 |
157 |
1 |
719 |
70 | 0 | 66 |
389 |
PLEKHF2 |
SE_02_115400104 |
chr8:95128598-95158352 |
Sample_02_1154 |
Lymphoma |
RL_R1446C_gRNA1_KDAC001 |
104 |
1 |
653 |
67 | 0 | 64 |
389 |
PLEKHF2 |
SE_01_004000032 |
chr8:95128602-95196598 |
Sample_01_0040 |
Haematopoietic and lymphoid tissue |
Karpas-422 |
32 |
3 |
1712 |
119 | 2 | 108 |
389 |
PLEKHF2 |
SE_02_115300120 |
chr8:95128630-95157246 |
Sample_02_1153 |
Lymphoma |
RL_R1446C_gRNA1 |
120 |
1 |
629 |
65 | 0 | 64 |
389 |
PLEKHF2 |
SE_02_011700023 |
chr8:95128631-95196346 |
Sample_02_0117 |
Haematopoietic and lymphoid tissue |
KARPAS-422 |
23 |
8 |
1696 |
119 | 1 | 108 |
389 |
PLEKHF2 |
SE_02_046000672 |
chr8:95128882-95151698 |
Sample_02_0460 |
Blood |
ME-1_I-10-49_6h |
672 |
10 |
501 |
57 | 0 | 28 |
186 |
PLEKHF2 |
SE_02_122500144 |
chr8:95129060-95191069 |
Sample_02_1225 |
Bone marrow |
RAJI |
144 |
23 |
1546 |
109 | 1 | 105 |
389 |
PLEKHF2,LINC01298 |
SE_02_045900813 |
chr8:95129127-95149894 |
Sample_02_0459 |
Blood |
ME-1_DMSO_6h |
813 |
8 |
453 |
49 | 0 | 28 |
186 |
PLEKHF2 |
SE_02_064501944 |
chr8:95129163-95136140 |
Sample_02_0645 |
Tracheobronchial epithelial |
HTBE_H1N1_18h |
1944 |
2 |
140 |
15 | 0 | 25 |
186 |
PLEKHF2 |
SE_00_000500227 |
chr8:95129199-95182910 |
Sample_00_0005 |
Blood |
B-cell |
227 |
12 |
1273 |
89 | 1 | 92 |
389 |
PLEKHF2 |
SE_02_094800855 |
chr8:95129385-95152294 |
Sample_02_0948 |
Pharyng |
Detroit562 |
855 |
6 |
507 |
58 | 0 | 28 |
186 |
PLEKHF2 |
SE_02_107700291 |
chr8:95129410-95138158 |
Sample_02_1077 |
Mammary gland |
MCF7_TET2KO-E2 |
291 |
3 |
173 |
18 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_002500120 |
chr8:95129903-95181745 |
Sample_02_0025 |
Blood |
CD19donorA |
120 |
31 |
1216 |
86 | 1 | 92 |
389 |
PLEKHF2 |
SE_02_139300726 |
chr8:95130129-95143738 |
Sample_02_1393 |
Lymph node |
anaplastic large cell lymphoma cells_ALK+#54 |
726 |
5 |
284 |
30 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_115800173 |
chr8:95131111-95148040 |
Sample_02_1158 |
Mammary gland |
MCF7_siYTHDC1_E2 |
173 |
6 |
368 |
39 | 0 | 28 |
186 |
PLEKHF2 |
SE_02_040400047 |
chr8:95131273-95160620 |
Sample_02_0404 |
Mammary gland |
ZR-75-1_2 |
47 |
4 |
658 |
64 | 0 | 64 |
389 |
PLEKHF2 |
SE_02_062400231 |
chr8:95131936-95143872 |
Sample_02_0624 |
Mammary gland |
TAMR_VEH |
231 |
3 |
262 |
27 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_062300263 |
chr8:95131984-95144517 |
Sample_02_0623 |
Mammary gland |
TAMR_E2 |
263 |
5 |
268 |
27 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_077800298 |
chr8:95132045-95138638 |
Sample_02_0778 |
Mammary gland |
MCF7_FASR |
298 |
2 |
137 |
17 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_136101332 |
chr8:95132121-95138343 |
Sample_02_1361 |
Bladder |
UMUC1_sonic_pSIN-puro_WTUTX |
1332 |
1 |
133 |
15 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_109300607 |
chr8:95132261-95144011 |
Sample_02_1093 |
Mammary gland |
T47D_shCtrl_shRING1B_24hr |
607 |
6 |
261 |
27 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_108800614 |
chr8:95132291-95143622 |
Sample_02_1088 |
Mammary gland |
T47D_shCtrl_45min |
614 |
3 |
255 |
27 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_098901611 |
chr8:95132615-95177368 |
Sample_02_0989 |
Kidney |
kidney cortex_WT |
1611 |
19 |
1036 |
81 | 1 | 90 |
389 |
PLEKHF2,LINC01298 |
SE_02_108300967 |
chr8:95132858-95155495 |
Sample_02_1083 |
Macula |
macula |
967 |
9 |
518 |
58 | 0 | 57 |
317 |
PLEKHF2 |
SE_02_146600628 |
chr8:95132880-95138249 |
Sample_02_1466 |
Blood |
HUDEP-2_BCL11AKO |
628 |
2 |
116 |
15 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_081700581 |
chr8:95132974-95138979 |
Sample_02_0817 |
Ovary |
Epithelial ovarian cancer |
581 |
3 |
127 |
19 | 0 | 26 |
186 |
PLEKHF2 |
SE_02_122400813 |
chr8:95133702-95160215 |
Sample_02_1224 |
Bone marrow |
normal plasma cell |
813 |
13 |
598 |
62 | 0 | 62 |
339 |
PLEKHF2 |
SE_02_130300252 |
chr8:95133745-95156624 |
Sample_02_1303 |
Lymphoma |
RL_tazemetostat |
252 |
1 |
520 |
58 | 0 | 60 |
312 |
PLEKHF2 |
SE_02_109100468 |
chr8:95133749-95144025 |
Sample_02_1091 |
Mammary gland |
T47D_shCtrl_shRING1B_8hr |
468 |
4 |
223 |
26 | 0 | 24 |
126 |
PLEKHF2 |
SE_02_067100308 |
chr8:95133767-95144102 |
Sample_02_0671 |
Mammary gland |
breast cancer_DSG |
308 |
3 |
225 |
26 | 0 | 24 |
121 |
PLEKHF2 |
SE_02_130400285 |
chr8:95133771-95157023 |
Sample_02_1304 |
Lymphoma |
RL_lenalidomide_tazemetostat |
285 |
1 |
529 |
59 | 0 | 61 |
323 |
PLEKHF2 |
SE_02_076901114 |
chr8:95133772-95151781 |
Sample_02_0769 |
Ovary |
HEYA8 |
1114 |
8 |
414 |
52 | 0 | 25 |
120 |
PLEKHF2 |
SE_02_133800226 |
chr8:95133790-95151717 |
Sample_02_1338 |
Esophagus |
KYSE180 |
226 |
9 |
412 |
52 | 0 | 24 |
117 |
PLEKHF2 |
SE_01_009600149 |
chr8:95133791-95151643 |
Sample_01_0096 |
B-cell lymphoma |
DOHH2 |
149 |
1 |
409 |
52 | 0 | 24 |
116 |
PLEKHF2 |
SE_02_067000159 |
chr8:95133814-95139713 |
Sample_02_0670 |
Mammary gland |
breast cancer FA |
159 |
3 |
123 |
18 | 0 | 20 |
105 |
PLEKHF2 |